GLP-1 medications have moved from niche treatments to one of the most significant growth drivers in health system pharmacy. This session examines how pharmacy leaders are building infrastructure, managing formulary complexity and positioning their organizations to capture clinical and financial returns from the ongoing surge in GLP-1 demand and innovation.